<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 13 May 2026 04:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors</title>
   <link>http://www.streetinsider.com/Press+Releases/Anaveon+Appoints+Thomas+P.+Mathers+as+Chair+of+the+Board+of+Directors/26480382.html</link>
   <description>&lt;p&gt;BASEL, Switzerland, May  13, 2026  (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the appointment of &lt;strong&gt;Thomas P. Mathers&lt;/strong&gt; as Chair of its Board of Directors. His appointment will be confirmed in the upcoming Annual General Meeting in June. Dieter Weinand, who served as Chair since 2024, has stepped down from the Board.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Mr. Mathers&lt;/strong&gt; brings over 32 years of distinguished executive leadership in the life sciences sector, with a proven track record in company building, capital raising, public market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Anaveon+Appoints+Thomas+P.+Mathers+as+Chair+of+the+Board+of+Directors/26480382.html</guid>
   <pubDate>Wed, 13 May 2026 04:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Anaveon+Appoints+Thomas+P.+Mathers+as+Chair+of+the+Board+of+Directors/26480382.html</link>
   <description>&lt;p&gt;BASEL, Switzerland, May  13, 2026  (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the appointment of &lt;strong&gt;Thomas P. Mathers&lt;/strong&gt; as Chair of its Board of Directors. His appointment will be confirmed in the upcoming Annual General Meeting in June. Dieter Weinand, who served as Chair since 2024, has stepped down from the Board.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Mr. Mathers&lt;/strong&gt; brings over 32 years of distinguished executive leadership in the life sciences sector, with a proven track record in company building, capital raising, public market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Anaveon+Appoints+Thomas+P.+Mathers+as+Chair+of+the+Board+of+Directors/26480382.html</guid>
   <pubDate>Wed, 13 May 2026 04:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</link>
   <description>si-local-file:///var/storage/newsbody/2018/0410/14038615.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Former+CoLucid+CEO+Thomas+P.+Mathers+joins+Pappas+Capital+as+Partner/14038615.html</guid>
   <pubDate>Tue, 10 Apr 2018 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02975482</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06776549</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.19895510</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.20982585</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.28124509</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   CoLucid Pharmaceuticals,               Filed by: Novo A/S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+Novo+AS/12794489.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12794489.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+Novo+AS/12794489.html</guid>
   <pubDate>Thu, 20 Apr 2017 06:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  15-12B     CoLucid Pharmaceuticals,             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12662514.html</link>
   <description>si-local-file:///var/storage/secattach/20170313/12662514.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12662514.html</guid>
   <pubDate>Mon, 13 Mar 2017 16:37:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  EFFECT     CoLucid Pharmaceuticals,             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12632076.html</link>
   <description>si-local-file:///var/storage/secattach/20170306/12632076.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12632076.html</guid>
   <pubDate>Mon, 06 Mar 2017 06:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    CoLucid Pharmaceuticals,             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622687.html</link>
   <description>si-local-file:///var/storage/secattach/20170302/12622687.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622687.html</guid>
   <pubDate>Thu, 02 Mar 2017 15:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  S-8 POS    CoLucid Pharmaceuticals,             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622666.html</link>
   <description>si-local-file:///var/storage/secattach/20170302/12622666.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8+POS++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622666.html</guid>
   <pubDate>Thu, 02 Mar 2017 15:55:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  POS AM     CoLucid Pharmaceuticals,             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622646.html</link>
   <description>si-local-file:///var/storage/secattach/20170302/12622646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++POS+AM+++++CoLucid+Pharmaceuticals%2C+++++++++++++/12622646.html</guid>
   <pubDate>Thu, 02 Mar 2017 15:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   CoLucid Pharmaceuticals,               Filed by: GAMCO INVESTORS, INC. ET AL</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+GAMCO+INVESTORS%2C+INC.+ET+AL/12621263.html</link>
   <description>si-local-file:///var/storage/secattach/20170302/12621263.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+GAMCO+INVESTORS%2C+INC.+ET+AL/12621263.html</guid>
   <pubDate>Thu, 02 Mar 2017 11:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: LILLY ELI &amp;amp; CO</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+LILLY+ELI+%26amp%3B+CO/12617287.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12617287.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+LILLY+ELI+%26amp%3B+CO/12617287.html</guid>
   <pubDate>Wed, 01 Mar 2017 17:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  SC 13D/A   CoLucid Pharmaceuticals,               Filed by: LILLY ELI &amp;amp; CO</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+LILLY+ELI+%26amp%3B+CO/12617086.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12617086.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++CoLucid+Pharmaceuticals%2C+++++++++++++++Filed+by%3A+LILLY+ELI+%26amp%3B+CO/12617086.html</guid>
   <pubDate>Wed, 01 Mar 2017 16:55:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  8-K        CoLucid Pharmaceuticals,  For: Mar 01</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01/12617004.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12617004.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01/12617004.html</guid>
   <pubDate>Wed, 01 Mar 2017 16:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: PAPPAS ARTHUR M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+PAPPAS+ARTHUR+M/12615563.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12615563.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+PAPPAS+ARTHUR+M/12615563.html</guid>
   <pubDate>Wed, 01 Mar 2017 15:35:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: White Marvin L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+White+Marvin+L/12614256.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614256.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+White+Marvin+L/12614256.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: Skwierczynski Raymond</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Skwierczynski+Raymond/12614238.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614238.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Skwierczynski+Raymond/12614238.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: Mathers Thomas P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Mathers+Thomas+P./12614212.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614212.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Mathers+Thomas+P./12614212.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: Marengere Luc</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Marengere+Luc/12614189.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614189.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Marengere+Luc/12614189.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: Lawton Alison Frances</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Lawton+Alison+Frances/12614171.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614171.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Lawton+Alison+Frances/12614171.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
  <item>
   <title>Form  4          CoLucid Pharmaceuticals,  For: Mar 01  Filed by: Kuca Bernice</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Kuca+Bernice/12614157.html</link>
   <description>si-local-file:///var/storage/secattach/20170301/12614157.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CoLucid+Pharmaceuticals%2C++For%3A+Mar+01++Filed+by%3A+Kuca+Bernice/12614157.html</guid>
   <pubDate>Wed, 01 Mar 2017 12:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLCD</category>
   	  </item>
 </channel>
</rss>
